Abstract:Objective By comparing three construction methods of mouse lung sarcoidosis models, which concludes MWCNTs, MWCNTs + lipopolysaccharide (LPS) intratracheal instillation, and MWCNTs + LPS aerosolization to provide a basis for subsequent research.Methods Forty male C57BL/6 mice were randomly divided into a control group, an MWCNT group, an MWCNT + LPS tracheal instillation group, and an MWCNT + LPS nebulization group, with 10 mice in each group. Mice in the control group received tracheal instillation of the same volume of physiological saline, while mice in the other groups received tracheal instillation of 60 μL of an 8 mg/kg MWCNT suspension. In addition, the MWCNT + LPS tracheal instillation group received concurrent tracheal instillation of LPS solution (5 mg/kg, 7 days per dose). and the MWCNT + LPS nebulization group received nebulization of LPS solution (5 mg/mL, 30 minutes per session, 7 days per week). The treatment lasted for 28 days, and tissue samples were collected on day 29. Mouse lung function was assessed [tidal volume (TV), minute ventilation (MV), specific airway resistance (sRaw), functional residual capacity (FRC) ], and lung imaging and histopathology were observed. Immunohistochemistry was used to detect the expression of macrophage marker F4/80 and lymphocyte marker CD3+T protein. Inflammatory cell counts in bronchoalveolar lavage fluid (BALF) were determined, and lung injury was assessed using LDH and BCA assays. White blood cell proportions were analyzed by blood cell classification, and levels of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukin-2 (IL-2) in BALF were measured by ELISA.Results Comparisons of TV, MV, and FRC levels among the groups showed no statistically significant differences (P > 0.05); however, comparisons of sRaw levels among the groups revealed statistically significant differences (P < 0.05), with increased sRaw levels observed in the MWCNT + LPS tracheal instillation group. Pulmonary imaging revealed that the right lung of the MWCNT group showed a single round solid nodule, the left lung of the MWCNT + LPS tracheal instillation group showed patchy ground-glass opacities, and the right lung of the MWCNT + LPS nebulization group showed a single small patchy lesion. Pulmonary histopathology showed that the lungs of the control group were smooth and tender; MWCNT group mice had black deposits in the lungs with white sarcoidosis on the surface; MWCNT + LPS tracheal instillation group mice had a large amount of black carbon nanotube deposits visible to the naked eye, accompanied by the formation of numerous white sarcoidosis; MWCNT + LPS nebulization group mice had tender lungs with a large amount of black deposits in the central region and visible nodular lesions. HE staining showed that the alveolar tubes and alveoli of the control group mice were well-organized; the lungs of the MWCNT group mice exhibited multifocal mild granulomas; the lungs of the MWCNT + LPS tracheal instillation group mice exhibited moderate multifocal granulomas; and the lungs of the MWCNT + LPS nebulization group mice exhibited multifocal mild granulomas. Immunohistochemical staining results showed that compared with the control group, F4/80 and CD3+T cells were slightly infiltrated in the lung tissue of the MWCNT group; in the MWCNT + LPS tracheal instillation group, F4/80 showed focal infiltration with strong cytoplasmic staining, and CD3+T cells were distributed in focal areas; In the MWCNT + LPS aerosol group, F4/80 and CD3+ cells showed diffuse infiltration and were widely distributed in the interstitial tissue. BALF cell classification showed that, compared with the blank group, the number of neutrophils in the BALF of mice in the MWCNT group, MWCNT + LPS tracheal instillation group, and MWCNT + LPS nebulization group significantly increased (P < 0.05), and a large number of macrophages appeared in the MWCNT + LPS tracheal instillation group. Lung injury results showed that there were statistically significant differences in LDH levels in BALF among the groups (P < 0.05). Compared with the control group, there was no statistically significant difference in LDH levels in the MWCNT group (P > 0.05), while LDH levels were elevated in the MWCNT + LPS tracheal instillation group (P < 0.05). There were no statistically significant differences in BCA levels in BALF among the groups (P > 0.05). Peripheral blood leukocyte differential counts showed that, compared with the control group, the MWCNT + LPS tracheal instillation group had elevated monocyte and eosinophil counts (P < 0.05); Eosinophil counts were elevated in the MWCNT + LPS nebulization group (P < 0.05), while there were no statistically significant differences in neutrophil, lymphocyte, and monocyte counts (P > 0.05). ELISA results showed that, compared with the control group, TNF-α levels were elevated in the MWCNT group (P < 0.05), while there were no statistically significant differences in INF-γand IL-2 levels (P > 0.05); In the MWCNT + LPS tracheal instillation group, levels of INF-γ, TNF-α, and IL-2 were all elevated (P < 0.05); in the MWCNT + LPS aerosol group, levels of INF-γ, TNF-α, and IL-2 were also all elevated (P < 0.05).Conclusions All three methods, MWCNT, MWCNT + LPS tracheal instillation and MWCNT + LPS aerosolization, could successfully construct lung sarcoidosis models. Among which the mouse lung sarcoidosis model constructed by the MWCNT + LPS nebulization method was able to effectively mimic a number of key features of the pathophysiology of human sarcoidosiss, which provided a valuable experimental model for the study of the mechanism of lung sarcoidosiss and drug development.